Expression of VEGFA-mRNA in classical and MSX2-mRNA in non-classical monocytes in patients with spondyloarthritis is associated with peripheral arthritis
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-89037-2
Abstract: Spondyloarthritis (SpA) is characterized by chronic inflammation and structural damage involving spine and peripheral joints. Monocytes, as part of innate immune system, following migration into affected tissue, may play a role in the pathogenesis of… read more here.
Keywords: peripheral arthritis; classical msx2; non classical; expression ... See more keywords
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac174
Abstract: OBJECTIVES Many axial spondylarthritis (axSpA) patients receive a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) in combination with a tumour necrosis factor inhibitor (TNFi). However, the value of this co-therapy remains unclear. The objectives were to… read more here.
Keywords: retention; axial spondylarthritis; peripheral arthritis; remission ... See more keywords
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC
Sign Up to like & getrecommendations! Published in 2017 at "RMD Open"
DOI: 10.1136/rmdopen-2016-000366
Abstract: Objective To describe the course and the 4-year outcome of juvenile spondyloarthritis (jSpA). Methods Patients with a diagnosis of jSpA and an age at onset ≤16 years were included in the German Spondyloarthritis Inception cohort (GESPIC)… read more here.
Keywords: peripheral arthritis; course patients; years observation; juvenile spondyloarthritis ... See more keywords